Deep Tech Startups

ClearPoint Neuro develops neurosurgical guidance systems and platforms that enable precise navigation to the brain and spine for device, cell, and gene therapy procedures. The company serves neurosurgery centers and supports clinical drug delivery trials through live MRI-guided and image-guided technology.

1 investor

ClicBio develops oral small-molecule CLIC1 inhibitors to treat metabolic diseases by modulating appetite through hypothalamic neuron regulation. The company targets obesity and metabolic disease through a mechanism that acts independently from and additively with GLP-1 agonists.

1 investor

CLLEVERT develops laboratory instrumentation and diagnostic technology solutions, with expertise in biochemistry, materials science, and clinical diagnostics. The company transforms advanced research into practical laboratory equipment and methods for improved efficiency and sustainability.

1 investor

Cloudberry is a €30M early-stage venture capital fund investing €400K to €1M into pre-seed and seed startups working on semiconductors, photonics, and advanced materials, mainly in Europe. It backs companies across the semiconductor value chain, from design tools and metrology to compute, electronics, and photonic sensing systems.

1 investor

Clounix designs and develops advanced network and communication chips and software solutions for telecommunications and digital transformation customers, enabling secure next-generation intelligent network infrastructure.

1 investor

Clyde Biosciences is a contract research organization offering predictive cardiac safety and efficacy testing using human iPSC-derived cardiomyocyte models, aimed at pharmaceutical and biotech teams assessing cardiotoxicity for clinical translation. It provides functional cardiac safety data aligned with regulatory guidance, including the CiPA Assay.

1 investor

Clyde Hydrogen develops modular hydrogen production systems ranging from 100kW to 100MW+ for applications including emergency backup power, industrial energy storage, and mobility refueling. The company's technology uses standardized modules (reductor, storage, and reactor) to enable flexible, scalable hydrogen generation and storage.

1 investor

CN Action manufactures precision testing power supplies and power conversion equipment for industrial, research, and infrastructure applications. The company produces testing power supplies, power quality control systems, industrial power supplies, and specialized power solutions for sectors including railways, aviation, power grids, and new energy.

1 investor

CO2Volt develops high-performance acidic CO₂ electrolysers that convert captured carbon dioxide into valuable chemicals, fuels, and industrial feedstocks. The company's technology targets hard-to-abate industries including aviation (sustainable aviation fuel), semiconductors, steel, and glass, with significantly improved durability and selectivity compared to conventional electrolysers.

1 investor

Coanda is a research and engineering firm that brings together scientists, engineers, and technologists to solve technical challenges for clients across various industries.

1 investor

Coastar Therapeutics develops gene delivery technologies using erythrocyte-derived membranes to enable genetic medicines for cancer immunotherapy and gene therapies. The company works with pharmaceutical and biotech partners to deliver therapeutics with improved immune evasion and precision targeting.

1 investor

Cocuus develops production technology for the food industry, with a focus on meat processing, to create nutritious and sustainable food products.

1 investor

Code Biotherapeutics develops a proprietary non-viral 3DNA delivery platform for genetic medicines, RNAi, and other modalities, using targeting molecules to reach specific cells and tissues outside the liver. The platform is designed for re-dosing, delivery of large gene constructs approaching 10kb, and modular manufacturing for genetic medicine development.

1 investor

Code Greene is a digital solutions firm offering web development, eCommerce, applications, and technology consulting services. The company also acquires and brings innovative technology products to market, manages intellectual property and digital infrastructure, and provides marketing and sales services.

1 investor

Codelucida develops error-correction coding technology for flash memory (NAND) storage. Its solutions target flash memory and storage device makers.

1 investor

Codexis provides enzyme engineering and biocatalysis services for RNA and small molecule API manufacturing, offering RNAi/siRNA and enzymatic synthesis solutions to pharmaceutical partners. It supports customers from process development through scalable commercial supply using an in-house pilot plant and CMO network.

1 investor

Cofibrant develops CI/CD pipeline tools that analyze C and C++ source code and insert runtime guards into binaries to prevent memory-corruption exploits such as remote code execution, without code changes or a new toolchain. It targets teams maintaining legacy and firmware codebases in memory-unsafe languages, positioning itself in the application security category.

1 investor

CoFound is an early-stage venture firm that invests in founders from the "ambition stage" and works closely with them on go-to-market strategy and finding product-market fit. It focuses on areas including deep tech and AI.

1 investor

CognaSIM develops AI-powered simulation software to help engineering teams design and test products more efficiently. The platform aims to replace legacy CAE tools with an accessible, user-friendly solution for product design, R&D, and manufacturing workflows.

1 investor

Cognigenics is developing iRNAi, a non-invasive intranasal RNA interference platform that delivers programmable RNA therapeutics directly to targeted brain circuits, bypassing the blood-brain barrier to modulate mood, memory, and cognition. The company focuses on precision neuropsychiatry and treatments for neurological and psychiatric disorders.

1 investor

RZX Tecnologia develops neuroscience-based solutions to improve safety and efficiency in oil and gas drilling operations by optimizing cognitive performance and reducing human error in complex operational environments.

1 investor

Coherence Bio makes Keystone, a benchtop laboratory instrument that integrates cell culture, fluid handling, scheduled interventions, and multimodal imaging into a single uninterrupted multi-day run. It is aimed at research labs running organoid, spheroid, and other multi-day cell biology protocols such as longitudinal phenotyping and drug response kinetics.

1 investor

Coherent Biopharma (Tongyi Pharmaceutical) is a biopharmaceutical company developing its proprietary Bi-targeting XDC (bi-XDC) conjugate drug platform to make previously undruggable targets treatable, with a focus on oncology. It has a pipeline of first-in-class candidates and clinical trials across multiple cancer indications, operating in China, the U.S., and Australia.

1 investor

Coinplug (CPLABS) builds blockchain-based infrastructure and technology, working with financial, telecom, and government organizations on digital identity and related projects. Founded in 2013, the company holds numerous patents and serves partners primarily across Asia.

1 investor